Literature DB >> 30099983

Differential relationship between colorectal cancer and diabetes in a nationally representative sample of adults.

Daniel Restifo1, Joni S Williams2, Emma Garacci3, Rebekah J Walker2, Mukoso N Ozieh4, Leonard E Egede5.   

Abstract

BACKGROUND: Diabetes has been identified as a risk factor for developing colorectal cancer (CRC); however, the literature identifying groups most at risk is sparse. This study aims to understand the relationship between CRC and diabetes by age and race/ethnicity.
METHODS: This is a cross-sectional study of data from the 2001-2014 National Health and Nutrition Examination Survey (unweighted n = 37,173; weighted n = 214,363,348). Individuals were categorized as having CRC if diagnosed with colon or rectal cancer and as having diabetes if told by a doctor they had diabetes, were taking insulin, or had an HbA1c ≥ 6.5%. Covariates included gender, age, race, marital status, educational level and income as a ratio of the poverty line. Multivariable logistic regression was used to assess the relationship between CRC and diabetes overall and stratified by age and by race.
RESULTS: 24.32% of the sample with CRC also had diabetes. After adjusting for covariates, individuals with diabetes had a 47% greater probability of having CRC (p = 0.03). While significance did not persist after stratification for those ≥65 years (OR = 1.06, p = 0.74), those <65 years with diabetes had nearly 5-times higher odds of having CRC (OR = 4.78, p < 0.001). When stratified by race, both groups had statistically higher odds of having CRC; however, the odds for non-whites (OR = 1.87, p = 0.04) were higher compared to whites (OR = 1.54, p = 0.03).
CONCLUSION: Individuals younger than 65 and racial/ethnic minorities have higher odds of CRC when also diagnosed with diabetes. Targeted interventions for these populations, especially regarding screening recommendations, may result in earlier detection of CRC and improved health outcomes.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Age disparities; Colorectal cancer; Diabetes; Health inequities; Racial disparities

Mesh:

Year:  2018        PMID: 30099983      PMCID: PMC8011301          DOI: 10.1016/j.jdiacomp.2018.06.007

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  43 in total

1.  Determinants of racial/ethnic colorectal cancer screening disparities.

Authors:  Anthony F Jerant; Joshua J Fenton; Peter Franks
Journal:  Arch Intern Med       Date:  2008-06-23

2.  Different risk factors for advanced colorectal neoplasm in young adults.

Authors:  Ji Yeon Kim; Yoon Suk Jung; Jung Ho Park; Hong Joo Kim; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim; Kyu Yong Choi; Dong Il Park
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

3.  Colorectal Cancer Incidence Patterns in the United States, 1974-2013.

Authors:  Rebecca L Siegel; Stacey A Fedewa; William F Anderson; Kimberly D Miller; Jiemin Ma; Philip S Rosenberg; Ahmedin Jemal
Journal:  J Natl Cancer Inst       Date:  2017-08-01       Impact factor: 13.506

4.  Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients.

Authors:  Yu-Xiao Yang; Sean Hennessy; James D Lewis
Journal:  Gastroenterology       Date:  2004-10       Impact factor: 22.682

5.  Patterns of colorectal cancer screening uptake among men and women in the United States.

Authors:  Helen I Meissner; Nancy Breen; Carrie N Klabunde; Sally W Vernon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-02       Impact factor: 4.254

Review 6.  Diabetes health disparities: a systematic review of health care interventions.

Authors:  Monica E Peek; Algernon Cargill; Elbert S Huang
Journal:  Med Care Res Rev       Date:  2007-10       Impact factor: 3.929

7.  The impact of colorectal cancer screening on the US population: is it time to celebrate?

Authors:  Chyke A Doubeni
Journal:  Cancer       Date:  2014-06-03       Impact factor: 6.860

8.  Treatment differences between blacks and whites with colorectal cancer.

Authors:  J K Ball; A Elixhauser
Journal:  Med Care       Date:  1996-09       Impact factor: 2.983

9.  Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain.

Authors:  Valentina Rosato; Alessandra Tavani; Esther Gracia-Lavedan; Elisabet Guinó; Gemma Castaño-Vinyals; Cristina M Villanueva; Manolis Kogevinas; Jerry Polesel; Diego Serraino; Federica E Pisa; Fabio Barbone; Victor Moreno; Carlo La Vecchia; Cristina Bosetti
Journal:  Front Oncol       Date:  2016-10-06       Impact factor: 6.244

10.  Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth.

Authors:  Giuseppina Imperatore; James P Boyle; Theodore J Thompson; Doug Case; Dana Dabelea; Richard F Hamman; Jean M Lawrence; Angela D Liese; Lenna L Liu; Elizabeth J Mayer-Davis; Beatriz L Rodriguez; Debra Standiford
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112

View more
  2 in total

1.  Glucose Intolerance and Cancer Risk: A Community-Based Prospective Cohort Study in Shanghai, China.

Authors:  Juzhong Ke; Tao Lin; Xiaolin Liu; Kang Wu; Xiaonan Ruan; Yibo Ding; Wenbin Liu; Hua Qiu; Xiaojie Tan; Xiaonan Wang; Xi Chen; Zhitao Li; Guangwen Cao
Journal:  Front Oncol       Date:  2021-08-30       Impact factor: 6.244

2.  Obesity, diabetes and the risk of colorectal adenoma and cancer.

Authors:  Ghodratollah Soltani; Arash Poursheikhani; Maryam Yassi; Abdorasool Hayatbakhsh; Matin Kerachian; Mohammad Amin Kerachian
Journal:  BMC Endocr Disord       Date:  2019-10-29       Impact factor: 2.763

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.